Frontiers in Cardiovascular Medicine (Mar 2022)

Paroxysmal Atrial Fibrillation in Elderly: Worldwide Preliminary Data of LINAC-Based Stereotactic Arrhythmia Radioablation Prospective Phase II Trial

  • Antonio Di Monaco,
  • Antonio Di Monaco,
  • Fabiana Gregucci,
  • Ilaria Bonaparte,
  • Federica Troisi,
  • Alessia Surgo,
  • Domenico Di Molfetta,
  • Nicola Vitulano,
  • Federico Quadrini,
  • Roberta Carbonara,
  • Gaetano Martinelli,
  • Pietro Guida,
  • Maria Paola Ciliberti,
  • Alba Fiorentino,
  • Massimo Grimaldi

DOI
https://doi.org/10.3389/fcvm.2022.832446
Journal volume & issue
Vol. 9

Abstract

Read online

Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. The reported data of the first 5 patients worldwide, showed no side effects, absence of AF episodes and without antiarrhythmic drugs.Trial Registration:ClinicalTrials.gov, identifier: NCT04575662.

Keywords